Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

Clinical trial NCT06922253 · COMPLETED

Trial details

NCT number: NCT06922253
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Heart Failure

Start date: 2024-12-28
Primary completion: 2025-01-20
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.